Last reviewed · How we verify

Butyphthalide combined with rtPA — Competitive Intelligence Brief

Butyphthalide combined with rtPA (Butyphthalide combined with rtPA) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed Small molecule Live · refreshed every 30 min

Target snapshot

Butyphthalide combined with rtPA (Butyphthalide combined with rtPA) — Hui-Sheng Chen.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Butyphthalide combined with rtPA TARGET Butyphthalide combined with rtPA Hui-Sheng Chen marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Butyphthalide combined with rtPA — Competitive Intelligence Brief. https://druglandscape.com/ci/butyphthalide-combined-with-rtpa. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: